MALAISE, Olivier ✱; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
PAULISSEN, Geneviève ✱; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
DEROYER, Céline ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
Ciregia, Federica
Poulet, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
NEUVILLE, Sophie ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
PLENER, Zelda ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
DANIEL, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > Département de chirurgie > Service de chirurgie de l'appareil locomoteur
Gillet, Philippe
LECHANTEUR, Chantal ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Laboratoire de thérapie cellulaire et génique (LTCG)
Brondello, Jean-Marc
DE SENY, Dominique ✱; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
MALAISE, Michel ✱; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie
Jeon, O.H.; Kim, C.; Laberge, R.M.; Demaria, M.; Rathod, S.; Vasserot, A.P.; Chung, J.W.; Kim, D.H.; Poon, Y.; David, N.; et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 2017, 23, 775–781.
Coryell, P.R.; Diekman, B.O.; Loeser, R.F. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat. Rev. Rheumatol. 2021, 17, 47–57.
Tachikart, Y.; Malaise, O.; Mumme, M.; Jorgensen, C.; Brondello, J.M. Seno-suppressive molecules as new therapeutic perspectives in rheumatic diseases. Biochem. Pharmacol. 2019, 165, 126–133.
He, S.; Sharpless, N.E. Senescence in Health and Disease. Cell 2017, 169, 1000–1011.
Hernandez-Segura, A.; de Jong, T.V.; Melov, S.; Guryev, V.; Campisi, J.; Demaria, M. Unmasking Transcriptional Heterogeneity in Senescent Cells. Curr. Biol. 2017, 27, 2652–2660.
D’Agostino, M.A.; Conaghan, P.; Le Bars, M.; Baron, G.; Grassi, W.; Martin-Mola, E.; Wakefield, R.; Brasseur, J.L.; So, A.; Backhaus, M.; et al. EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis. Ann. Rheum. Dis. 2005, 64, 1703–1709.
Atukorala, I.; Kwoh, C.K.; Guermazi, A.; Roemer, F.W.; Boudreau, R.M.; Hannon, M.J.; Hunter, D.J. Synovitis in knee osteoarthritis: A precursor of disease? Ann. Rheum. Dis. 2016, 75, 390–395.
de Seny, D.; Bianchi, E.; Baiwir, D.; Cobraiville, G.; Collin, C.; Deliège, M.; Kaiser, M.J.; Mazzucchelli, G.; Hauzeur, J.P.; Delvenne, P.; et al. Proteins involved in the endoplasmic reticulum stress are modulated in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score. Sci. Rep. 2020, 10, 14149.
Chou, C.H.; Jain, V.; Gibson, J.; Attarian, D.E.; Haraden, C.A.; Yohn, C.B.; Laberge, R.M.; Gregory, S.; Kraus, V.B. Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritis. Sci. Rep. 2020, 10, 10868.
Malaise, O.; Tachikart, Y.; Constantinides, M.; Mumme, M.; Ferreira-Lopez, R.; Noack, S.; Krettek, C.; Noël, D.; Wang, J.; Jorgensen, C.; et al. Mesenchymal stem cell senescence alleviates their intrinsic and senosuppressive paracrine properties contributing to osteoarthritis development. Aging 2019, 11, 9128–9146.
Diekman, B.O.; Sessions, G.A.; Collins, J.A.; Knecht, A.K.; Strum, S.L.; Mitin, N.K.; Carlson, C.S.; Loeser, R.F.; Sharpless, N.E. Expression of p16INK4a is a biomarker of chondrocyte aging but does not cause osteoarthritis. Aging Cell 2018, 17, e12771.
Koenig, K.M.; Ong, K.L.; Lau, E.C.; Vail, T.P.; Berry, D.J.; Rubash, H.E.; Kurtz, S.; Bozic, K.J. The Use of Hyaluronic Acid and Corticosteroid Injections Among Medicare Patients With Knee Osteoarthritis. J. Arthroplast. 2016, 31, 351–355.
McAlindon, T.E.; LaValley, M.P.; Harvey, W.F.; Price, L.L.; Driban, J.B.; Zhang, M.; Ward, R.J. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis a randomized clinical trial. JAMA 2017, 317, 1967–1975.
Fubini, S.L.; Todhunter, R.J.; Burton-Wurster, N.; Vernier-Singer, M.; MacLeod, J.N. Corticosteroids alter the differentiated phenotype of articular chondrocytes. J. Orthop. Res. 2001, 19, 688–695.
Xue, E.; Zhang, Y.; Song, B.; Xiao, J.; Shi, Z. Effect of autophagy induced by dexamethasone on senescence in chondrocytes. Mol. Med. Rep. 2016, 14, 3037–3044.
Poulsen, R.C.; Watts, A.C.; Murphy, R.J.; Snelling, S.J.; Carr, A.J.; Hulley, P.A. Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: In vivo and in vitro evidence. Ann. Rheum. Dis. 2014, 73, 1405–1413.
Lechanteur, C.; Briquet, A.; Giet, O.; Delloye, O.; Baudoux, E.; Beguin, Y. Clinical-scale expansion of mesenchymal stromal cells: A large banking experience. J. Transl. Med. 2016, 14, 145.
Relić, B.; Benoit, V.; Franchimont, N.; Ribbens, C.; Kaiser, M.J.; Gillet, P.; Merville, M.P.; Bours, V.; Malaise, M.G. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. J. Biol. Chem. 2004, 279, 22399–22403.
Deroyer, C.; Charlier, E.; Neuville, S.; Malaise, O.; Gillet, P.; Kurth, W.; Chariot, A.; Malaise, M.; de Seny, D. CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes. Cell Death Dis. 2019, 10, 103.
Mizuno, M.; Katano, H.; Mabuchi, Y.; Ogata, Y.; Ichinose, S.; Fujii, S.; Otabe, K.; Komori, K.; Ozeki, N.; Koga, H.; et al. Specific markers and properties of synovial mesenchymal stem cells in the surface, stromal, and perivascular regions. Stem Cell Res. Ther. 2018, 9, 123.
Maumus, M.; Manferdini, C.; Toupet, K.; Peyrafitte, J.A.; Ferreira, R.; Facchini, A.; Gabusi, E.; Bourin, P.; Jorgensen, C.; Lisignoli, G.; et al. Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis. Stem Cell Res. 2013, 11, 834–844.
Malaise, O.; Relic, B.; Quesada-Calvo, F.; Charlier, E.; Zeddou, M.; Neuville, S.; Gillet, P.; Louis, E.; De Seny, D.; Malaise, M.G. Selective glucocorticoid receptor modulator compound A, in contrast to prednisolone, does not induce leptin or the leptin receptor in human osteoarthritis synovial fibroblasts. Rheumatology 2015, 54, 1087–1092.
Relic, B.; Zeddou, M.; Desoroux, A.; Beguin, Y.; De Seny, D.; Malaise, M.G. Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Lab. Investig. 2009, 89, 811–822.
Malaise, O.; Relic, B.; Charlier, E.; Zeddou, M.; Neuville, S.; Deroyer, C.; Gillet, P.; Louis, E.; Malaise, M.G.; de Seny, D. Glucocorticoid-induced leucine zipper (GILZ) is involved in glucocorticoid-induced and mineralocorticoid-induced leptin production by osteoarthritis synovial fibroblasts. Arthritis Res. Ther. 2016, 18, 219.
de Seny, D.; Cobraiville, G.; Charlier, E.; Neuville, S.; Esser, N.; Malaise, D.; Malaise, O.; Calvo, F.Q.; Relic, B.; Malaise, M.G. Acute-Phase Serum Amyloid A in Osteoarthritis: Regulatory Mechanism and Proinflammatory Properties. PLoS ONE 2013, 8, e66769.
Li, N.; Gao, J.; Mi, L.; Zhang, G.; Zhang, L.; Zhang, N.; Huo, R.; Hu, J.; Xu, K. Synovial membrane mesenchymal stem cells: Past life, current situation, and application in bone and joint diseases. Stem Cell Res. Ther. 2020, 11, 381.
Liu, X.; Chai, Y.; Liu, G.; Su, W.; Guo, Q.; Lv, X.; Gao, P.; Yu, B.; Ferbeyre, G.; Cao, X.; et al. Osteoclasts protect bone blood vessels against senescence through the angiogenin/plexin-B2 axis. Nat. Commun. 2021, 12, 1832.
Wang, T.; Yang, L.; Liang, Z.; Wang, L.; Su, F.; Wang, X.; You, X.; He, C. Targeting cellular senescence prevents glucocorticoid-induced bone loss through modulation of the DPP4-GLP-1 axis. Signal Transduct. Target. Ther. 2021, 6, 143.
Sung, J.Y.; Kim, S.G.; Kim, J.R.; Choi, H.C. Prednisolone suppresses adriamycin-induced vascular smooth muscle cell senescence and inflammatory response via the SIRT1-AMPK signaling pathway. PLoS ONE 2020, 15, e0239976.
Bogarin, T.; Saraswathy, S.; Akiyama, G.; Xie, X.; Weinreb, R.N.; Zheng, J.; Huang, A.S. Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids. Exp. Eye Res. 2019, 187, 107774.
Martin, L.F.; Richardson, L.S.; Da Silva, M.G.; Sheller-Miller, S.; Menon, R. Dexamethasone induces primary amnion epithelial cell senescence through telomere-P21 associated pathway. Biol. Reprod. 2019, 100, 1605–1616.
Li, S.; Mawal-Dewan, M.; Cristofalo, V.J.; Sell, C. Enhanced proliferation of human fibroblasts, in the presence of dexamethasone, is accompanied by changes in p21(Waf1/Cip1/Sdi1) and the insulin-like growth factor type 1 receptor. J. Cell. Physiol. 1998, 177, 396–401.
Zannas, A.S.; Kosyk, O.; Leung, C.S. Prolonged glucocorticoid exposure does not accelerate telomere shortening in cultured human fibroblasts. Genes 2020, 11, 1425.
